Immuneering (IMRX) Current Assets (2020 - 2024)
Historic Current Assets for Immuneering (IMRX) over the last 5 years, with Q3 2024 value amounting to $55.3 million.
- Immuneering's Current Assets fell 4506.07% to $55.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $55.3 million, marking a year-over-year decrease of 4506.07%. This contributed to the annual value of $89.1 million for FY2023, which is 1808.16% down from last year.
- Latest data reveals that Immuneering reported Current Assets of $55.3 million as of Q3 2024, which was down 4506.07% from $63.7 million recorded in Q2 2024.
- In the past 5 years, Immuneering's Current Assets registered a high of $153.3 million during Q3 2021, and its lowest value of $37.7 million during Q4 2020.
- Over the past 5 years, Immuneering's median Current Assets value was $100.6 million (recorded in 2023), while the average stood at $98.7 million.
- Per our database at Business Quant, Immuneering's Current Assets soared by 30373.46% in 2021 and then plummeted by 4506.07% in 2024.
- Immuneering's Current Assets (Quarter) stood at $37.7 million in 2020, then soared by 303.73% to $152.3 million in 2021, then fell by 28.61% to $108.7 million in 2022, then decreased by 18.08% to $89.1 million in 2023, then crashed by 37.97% to $55.3 million in 2024.
- Its Current Assets stands at $55.3 million for Q3 2024, versus $63.7 million for Q2 2024 and $74.4 million for Q1 2024.